Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

How to Prepare for a WHO PQP Facility Audit

Posted on May 26, 2025 By digi

How to Prepare for a WHO PQP Facility Audit

Essential Steps to Prepare for a WHO PQP Facility Audit

For pharmaceutical manufacturers aiming to supply to global health organizations like UNICEF, Global Fund, or GAVI, obtaining WHO Prequalification is a key milestone. At the heart of this process lies the WHO PQP facility audit, a rigorous on-site inspection that verifies GMP compliance. Preparing for this audit requires strategic planning, robust quality systems, and thorough documentation control. This guide outlines how pharmaceutical professionals can prepare effectively for a WHO PQP facility audit and improve their chances of success.

Understanding the WHO PQP Audit Process:

The WHO PQP audit assesses whether a manufacturing site meets the standards defined in WHO TRS 986 and TRS 961. It includes an inspection of facilities, systems, documents, and personnel capabilities and is conducted by a team of trained WHO inspectors over 3–5 days.

Step 1: Internal GMP Readiness Assessment

Begin by conducting an internal self-inspection using WHO’s GMP checklist. This helps identify gaps early and prioritize remediation.

  • Use WHO TRS 986 Annex 2 as your reference document
  • Check alignment with ICH Q7/Q10 and WHO GMP clauses
  • Audit the entire quality system: change control, deviation management, CAPA, validation, etc.

Step 2: Assemble the Pre-Audit Documentation Package

WHO requires the submission of key documents before inspection scheduling. Ensure the following are current and accurate:

  • Site Master File (SMF): Comprehensive overview of the site’s infrastructure and operations
  • Validation Master Plan (VMP): Details of ongoing and completed validation activities
  • SOP index and key GMP procedures: Including deviation, change control, CAPA, training, cleaning
  • Recent batch records: For all products under review
  • Organograms and equipment lists
Also Read:  Impact of Harmonization on International Pharmaceutical Trade and Compliance

Step 3: Train Subject Matter Experts (SMEs)

The success of the audit heavily depends on how confidently your personnel respond to inspector questions. Conduct structured SME training to ensure:

  • QA, QC, Production, Engineering, and Warehouse leads know the SOPs
  • SMEs understand the WHO inspection process and global expectations
  • Consistent responses are given based on documented processes

Step 4: Simulate a WHO PQP Audit

Organize mock audits with internal or external auditors familiar with WHO’s approach. Simulate real conditions including:

  • Opening and closing meetings
  • Facility tour walkthroughs
  • Batch record traceability checks
  • Stability testing protocol evaluation
  • Audit trail review of electronic systems

Step 5: Prepare an Audit War Room and Response Plan

Set up a designated room equipped with:

  • Printed and digital SOPs, BMRs, SMF, and VMP
  • Assigned scribe, runner, SME, and QA point of contact
  • Document request log with tracking and delivery timelines
  • Audit room briefing board with daily inspector feedback summary
Also Read:  The Role of Inspection History in Global Market Access Decisions

Step 6: Clean and Calibrate the Facility

  • Ensure all cleaning logs and sanitation protocols are up to date
  • Calibration certificates must be current for all equipment
  • Gowning procedures, HVAC maintenance, pest control—all should be audit-ready

Step 7: Inspect Stability Study Controls

As WHO places strong emphasis on long-term and accelerated stability, confirm the following:

  • Data complies with ICH Q1A(R2) guidelines
  • Out-of-trend (OOT) and out-of-specification (OOS) results are properly investigated
  • All chambers have current qualification and continuous monitoring logs
  • Stability summaries support shelf-life claims on packaging

Step 8: Review Previous Audit Findings

If the facility has undergone other audits (e.g., by USFDA, EMA, or local NRAs), analyze the findings and corrective actions. WHO inspectors may ask about repeat deficiencies and systemic CAPA effectiveness.

Step 9: Rehearse the Opening Meeting

  • QA Head should prepare a site presentation
  • Explain company structure, site layout, quality systems, and prior WHO engagements
  • Be ready to present organization charts and key quality metrics

Step 10: Build a CAPA Framework in Advance

Prepare a template to log and respond to findings during the audit. Include fields for:

  • Observation classification (Critical, Major, Other)
  • Root cause analysis (RCA)
  • Corrective steps
  • Preventive actions
  • Timeline and responsible department
Also Read:  Evolution of International GMP Inspection Standards and Practices

Step 11: Prepare Teams for Real-Time Traceability Requests

WHO inspectors will often trace a batch from start to finish. Make sure:

  • Raw material receiving, storage, issuance, and usage are well-documented
  • Environmental monitoring data aligns with production timelines
  • QC testing records are linked with analytical methods and equipment IDs

Step 12: Align SOPs with WHO GMP Expectations

Ensure your SOPs reflect actual practices, include version control, and are compliant with WHO GMP modules including:

  • Document control
  • Training
  • Deviations and OOS handling
  • Self-inspections
  • Complaint handling

Post-Audit Considerations:

  • Submit your CAPA plan within 30 days
  • Track CAPA timelines and implementation status
  • Be ready for re-inspection or desk review if additional evidence is required
  • Document lessons learned and update training programs

Conclusion:

A WHO PQP facility audit is a pivotal milestone for any pharma organization aspiring to supply to global health markets. Preparation must be strategic, collaborative, and focused on quality systems. By aligning with WHO expectations, training your people, and simulating inspections, you can not only pass the audit—but also build a robust compliance culture that supports sustained regulatory trust and global impact.

International GMP Inspection Standards and Harmonization, WHO Prequalification and Inspection Systems Tags:GMP pre-audit checklist, pharma audit readiness, PQP dossier support, site master file WHO, WHO audit briefing, WHO audit preparation steps, WHO audit SME training, WHO audit SOPs, WHO audit validation readiness, WHO GMP audit checklist, WHO inspection CAPA, WHO inspection documents, WHO inspection readiness, WHO PQ compliance, WHO PQ inspection planning, WHO PQ mock audits, WHO PQP audit preparation, WHO PQP site visit, WHO prequalification facility audit

Post navigation

Previous Post: Steps Involved in WHO GMP Site Inspection
Next Post: Validate Cleaning Procedures for Both Dedicated and Shared Equipment

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Never Skip Root Cause Analysis During GMP Deviation Investigations

    Never Skip Root Cause Analysis… Read more

International GMP Inspection Standards and Harmonization

  • Global GMP Inspection Frameworks
  • WHO Prequalification and Inspection Systems
  • US FDA GMP Inspection Programs
  • EMA and EU GMP Inspection Practices
  • PIC/S Role in Harmonized Inspections
  • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)

International GMP Inspection Standards and Harmonization, WHO Prequalification and Inspection Systems

  • WHO Site Master File Requirements for GMP Prequalification
  • How to Prepare for a WHO PQP Facility Audit
  • Steps Involved in WHO GMP Site Inspection
  • WHO GMP Inspection Guidelines: Scope and Structure Explained
  • Overview of the WHO Prequalification Program: Scope, Process, and Global Role
  • Future Trends in Global GMP Inspection Frameworks
  • Challenges in Aligning National Regulations with Global GMP Inspection Practices
  • Using Inspection Metrics to Drive Continuous GMP Improvement
  • Role of QA Units in Preparing for Multi-National GMP Inspections
  • Leveraging Inspection Outcomes for Quality Risk Management

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme